Investors see it as a leader in next-gen personalized diagnostics. Its AI scans biomarkers for early warning signs. Many expect widespread use in routine healthcare.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
